These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 31129450

  • 1. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T, Makar S, Swetha R, Gutti G, Singh SK.
    Eur J Med Chem; 2019 Sep 01; 177():116-143. PubMed ID: 31129450
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.
    J Steroid Biochem Mol Biol; 2000 Nov 30; 74(5):279-85. PubMed ID: 11162936
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS, Jordan VC.
    Mutat Res; 2005 Dec 11; 591(1-2):247-63. PubMed ID: 16083919
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
    Katzenellenbogen BS, Katzenellenbogen JA.
    Breast Cancer Res; 2000 Dec 11; 2(5):335-44. PubMed ID: 11250726
    [Abstract] [Full Text] [Related]

  • 10. Accelerating drug development in breast cancer: New frontiers for ER inhibition.
    Ferraro E, Walsh EM, Tao JJ, Chandarlapaty S, Jhaveri K.
    Cancer Treat Rev; 2022 Sep 11; 109():102432. PubMed ID: 35839531
    [Abstract] [Full Text] [Related]

  • 11. Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges.
    Rej RK, Thomas JE, Acharyya RK, Rae JM, Wang S.
    J Med Chem; 2023 Jul 13; 66(13):8339-8381. PubMed ID: 37377342
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current and emerging estrogen receptor-targeted therapies for the treatment of breast cancer.
    Haines CN, Wardell SE, McDonnell DP.
    Essays Biochem; 2021 Dec 17; 65(6):985-1001. PubMed ID: 34328178
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment.
    Patel HK, Bihani T.
    Pharmacol Ther; 2018 Jun 17; 186():1-24. PubMed ID: 29289555
    [Abstract] [Full Text] [Related]

  • 16. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH, Komm BS.
    Post Reprod Health; 2015 Sep 17; 21(3):112-21. PubMed ID: 26289836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA.
    Recent Prog Horm Res; 2000 Sep 17; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [Abstract] [Full Text] [Related]

  • 19. Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors.
    Suba Z.
    Recent Pat Anticancer Drug Discov; 2018 Sep 17; 13(4):428-444. PubMed ID: 30027855
    [Abstract] [Full Text] [Related]

  • 20. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Baumann CK, Castiglione-Gertsch M.
    Minerva Ginecol; 2009 Dec 17; 61(6):517-39. PubMed ID: 19942839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.